5. Innate Immunity III.pdf

Embed Size (px)

Citation preview

  • 7/28/2019 5. Innate Immunity III.pdf

    1/37

    Innate Immunity (III)Soluble Molecules

  • 7/28/2019 5. Innate Immunity III.pdf

    2/37

    NK Cells

    First line of defenseagainst: Tumor cells

    Virally-infected cells Other intracellular

    pathogens

    Implicated in: Transplant rejection

    Autoimmunity

    Spontaneous abortions

    Christina Trambas, Cancer Council of Tasmania,

    http://www.ciml.univ-mrs.fr/fr/science/lab-eric-vivier/pour-specialistes

    NK Cell

    Tumor Cell

  • 7/28/2019 5. Innate Immunity III.pdf

    3/37

    Functions of NK

    1. Direct Cytotoxicity:Target cell lysis

    a. by perforines & granzymes

    b. By Ab dependent cellular cytotoxicity (ADCC)

  • 7/28/2019 5. Innate Immunity III.pdf

    4/37

    2. NK secrete IFNs: Enhance the activation of M

    Anti-viral activity

    Functions of NK (II)

  • 7/28/2019 5. Innate Immunity III.pdf

    5/37

    Discovery of Interferons

    Isaacs and Lindenmann (1957)

    Found a substance that interfered with

    viral replication and was therefore namedinterferon

    Nagano and Kojima also independently

    discovered this soluble antiviral protein

  • 7/28/2019 5. Innate Immunity III.pdf

    6/37

    What are Interferons?

    Naturally occurring family of proteins & glycoproteineach with slightly different physiological effects

    Genes (chr 9/12*) that synthesize IFN are activated

    when a host cell is invaded by a virus

    IFNs are secreted bycells of immune system : NK, lymphocytes

    eukaryotic cells in response to viral infections,tumors

  • 7/28/2019 5. Innate Immunity III.pdf

    7/37

    Interferon Family

    Main functions

    stimulates the healthy cells which are livingneighbor an infected cell to activate genes for an

    antiviral proteinblocks viral reproduction in the neighboring cell

    activate macrophages and mobilize NKs

  • 7/28/2019 5. Innate Immunity III.pdf

    8/37

    When a tissue cell is infected by avirus, it releases interferon.Interferon will diffuse to thesurrounding cells.When it binds to receptors on thesurface of those adjacent cells, theybegin the production of a protein thatprevents the synthesis of viralproteins.

    This prevents the spread of the virusthroughout the body.

    General Actionof Interferons

    Three types of interferons: alpha,beta and gamma.

  • 7/28/2019 5. Innate Immunity III.pdf

    9/37

    Type I InterferonsAlpha: produced by leukocytes

    Beta: produced by fibroblasts

    Largest group of interferons

    Receptors: interferon cell

    receptors type 1: stimulus for expression: viralinfection

    different binding affinities

    similar biological effects

    Roles

    Used to mobilize our 1st line ofdefense against invading organisms

  • 7/28/2019 5. Innate Immunity III.pdf

    10/37

    Anti-viraleffects of

    interferona/b

  • 7/28/2019 5. Innate Immunity III.pdf

    11/37

    Type II Interferon (gamma)

    Gamma: produced by

    TH1, CTLs NK

    B cells and professional antigen-presenting- cells

    stimuli for Gamma production:

    immune activationInflammatory state*

    Bind to type 2 receptors

  • 7/28/2019 5. Innate Immunity III.pdf

    12/37

    Innate Immune System

    First lineNatural Barriers:

    I. PhysicalII. Chemical

    III. Biological

    Second lineComponentes:

    I. Cells: NK, Phagocytes

    II. Soluble molecules

    III. Mechanisms

  • 7/28/2019 5. Innate Immunity III.pdf

    13/37

    Soluble molecules

    recognition distruction

    opsonization

    +phagocytosis + inflammation

    cellularlysis

  • 7/28/2019 5. Innate Immunity III.pdf

    14/37

    Soluble molecules

    1. Interferons

    (anti-viral proteins )2. Complement

    (Membranar AttackComplex)

    3. Beta lysine

    (antibacterial proteins)4. Lactoperoxydase

    (saliva & milk )

    5. Lysosim(anti-bacterial enzyme))

    1. Natural Ab (limitated

    specificity)2. Pentraxines(C Reactive Protein, serumamiloid P)

    3. Collectins

    (MBL, pulmonar surfactants)4. Ficolines

    (plasma proteins)

    recognition distruction

  • 7/28/2019 5. Innate Immunity III.pdf

    15/37

    Recognition Soluble Molecules

    Natural Abs: Produced by some subsets of LB limited number of

    specificities without overt exposure to foreign Ags Are present in plasma before the infection

    Recognize common non-self molecules Pentraxines:

    Recognize microbial structures Structure: pentameric proteins Members:

    Short PTX: Reactive C protein, serum amyloid P Long PTX: PTX3

    CRP: plasma conc low (N) 1000 fold during infection (phaseacute reactant)

  • 7/28/2019 5. Innate Immunity III.pdf

    16/37

    4. Ficolins:

    structure : Similar to collectins

    Role: recognize N-acetylglucosamin & acid

    lipotheicoicG+ bacteria

    Recognition Soluble Molecules

    3. Collectines: Family Members: MBL (manose-binding lectin) SP-A & SP-D (pulmonar surfactants

    Structure:

    collagen-like tail bound to lectinic calcium-dependent (C-type)sequence

    Role: recognize Man, Fru residuu

    Dupa Abas at al. 2012 Elsevier/Saunders

  • 7/28/2019 5. Innate Immunity III.pdf

    17/37

    Soluble molecules

    1. Interferons

    (anti-viral proteins )2. Complement(Membranar AttackComplex)

    3. Beta lysine

    (antibacterial proteins)4. Lactoperoxydase

    (saliva & milk )

    5. Lysosim(anti-bacterial enzyme))

    1. Natural Ab (limitated

    specificity)2. Pentraxines(C Reactive Protein, serumamiloid P)

    3. Collectins

    (MBL, pulmonar surfactants)4. Ficolines

    (plasma proteins)

    recognition distruction

  • 7/28/2019 5. Innate Immunity III.pdf

    18/37

    Complement (C) Definition

    Definition:Group of 30 different heat labile

    proteins, component of normal plasma exist normally in an inactive form

    (zymogen).When activated, they can enhance

    aspects of innate immunity & some ofthe biological effects of Abs their activity was said to complement

    antibacterial activity of antibodies

  • 7/28/2019 5. Innate Immunity III.pdf

    19/37

    C Protein Sources

    Nomenclature: are designated by letter C followed by a

    number (C1-C9) fragments obtained by cleavege a/b** Factors: B, D, P, H, I

    Source:Hepatocytes

    Tissue macrophagesEpithelial cells of the GIBlood monocytes

  • 7/28/2019 5. Innate Immunity III.pdf

    20/37

    The effector functions ofcomplement can be activated

    through 3 major pathways

    The Classical Pathway

    Lectin Pathway

    The Alternative Pathway

  • 7/28/2019 5. Innate Immunity III.pdf

    21/37

    Innate Immune Activation ofComplement Pathway:

    2 modes of initiation

  • 7/28/2019 5. Innate Immunity III.pdf

    22/37

    Alternative Pathway of

    Complement Activation

    Triggered by

    LPS Cell Walls of some bacteria andyeasts

    Cobra venom

    C f Al i

  • 7/28/2019 5. Innate Immunity III.pdf

    23/37

    Proteins structure Conc (g/dL) function

    C3 Heterodimer : 180kDa: terminal C: thiolesther domainTED2S

    : terminal N: bound C5

    1000-1200 Non-enzymatic Activated

    C3a: stimulate inflammation

    C3b: opsonin; component of

    C3 convertase

    Factor B

    (zymogen)

    Monomer: 93 kDA1 chain AA

    200 Bb=Ser protease: active form

    of C3 & C5 convertase

    Factor D

    (active

    protease

    Monomer 25 kDA 1-2 Plasmal Ser-protease

    Cleavage factor B

    FactorP

    /properdin

    Monomers 56KDa

    (max 4 subunits)

    25 Stabilize C3 convertase

    (C3bBb)

    Components of AlternativePathway of Complement

    Dupa Abas at al. 2012 Elsevier/Saunders

  • 7/28/2019 5. Innate Immunity III.pdf

    24/37

    Alternative Pathway ofComplement Activation

    Dupa Abas at al. 2012 Elsevier/Saunders

  • 7/28/2019 5. Innate Immunity III.pdf

    25/37

    Final Stages of C cascade

    Abas at al. 2012 Elsevier/Saunders

  • 7/28/2019 5. Innate Immunity III.pdf

    26/37

    3 Main Consequences ofComplement Activation

    Opsonization of Pathogens: C3b

    Acute Inflammation: C3a, C5a

    Killing of Pathogens: pore formation

  • 7/28/2019 5. Innate Immunity III.pdf

    27/37

    Functions of C system (a)

    Dupa Abas at al. 2012 Elsevier/Saunders

  • 7/28/2019 5. Innate Immunity III.pdf

    28/37

    Functions of C system (b)

  • 7/28/2019 5. Innate Immunity III.pdf

    29/37

    Functions of C system (b)

    Dupa Abas at al. 2012 Elsevier/Saunders

  • 7/28/2019 5. Innate Immunity III.pdf

    30/37

    Regulation of Complement

    Activation Regulators of Complement Activation

    Decay Accelerating Factor, Membrane

    Cofactor 1, Complement Receptor 1, C1Inhibitor etc.

    Inhibit formation of C3 convertase Breakdown and inactivate C3 and C5

    convertase Inhibit formation of MAC

  • 7/28/2019 5. Innate Immunity III.pdf

    31/37

    Regulation of Complement Activation

    Regulatory Protein placed on the surface of host cellprevent/dissociate formation of Bb complexDecay Accelerating Factor/ Complement Receptor 1,

    Membrane Cofactor 1

    Dupa Abas at al. 2012 Elsevier/Saunders

  • 7/28/2019 5. Innate Immunity III.pdf

    32/37

    Inhibition ofactivation of C

    Plasma Factors:

    H Factor: bound C3b & C3bBb complex

    Catalyze the activity of Ifactor

    I Factor (inhibitory): proteasecleavage bound C3b inactivC3b

    Dupa Thao Doan 2008; LWW

  • 7/28/2019 5. Innate Immunity III.pdf

    33/37

    The end

  • 7/28/2019 5. Innate Immunity III.pdf

    34/37

    34

    Interferon Family

    Interferons are a family of related

    Lymphocytes secrete gamma () interferon, but

    most other WBCs secrete alpha () interferon Fibroblasts secrete beta () interferon

    Interferons also activate macrophages andmobilize NKs

    FDA-approved alpha IFN is used: As an antiviral drug against hepatitis C virus

    To treat genital warts caused by the herpes virus

    4 I t f (IFN)

  • 7/28/2019 5. Innate Immunity III.pdf

    35/37

    35

    Interferon molecules leave the infected cell

    and enter neighboring cells

    Interferon stimulates the neighboring cells to

    activate genes for PKR (an antiviral protein) PKR nonspecifically blocks viral reproduction in the

    neighboring cell

    4 a. Interferon (IFN)

  • 7/28/2019 5. Innate Immunity III.pdf

    36/37

    The exact mechanism of type I interferons are not

    fully understood, but this is an idea of what

    happens: Alpha and beta bind to heterodimeric receptor on cell surface. Alpha receptor is made up of at least 2 polypeptide chains:

    IFNa-R1 and IFNa-R2

    IFNa-R1 is involved in signal transduction

    IFNa-R2 is the ligand-binding chain that also plays a role in

    signal transduction Ligation induces oligomerisation and initiation of the signal

    transduction pathway

    This results in phosphorylation of signal transductors andactivators of transcription proteins, which translocate to the

    nucleous as a trimeric complex, ISGF-3. ISGF-3 activates transcription of interferon stimulated genes,

    with many biological effects.

  • 7/28/2019 5. Innate Immunity III.pdf

    37/37

    Interferon Gamma Receptor

    Composed of two ligand binding IFNg-R1 chainsassociated with two signal transducing IFNg-R2chains

    The IFNg-R2 chain is generally the limiting factorin IFNg responsiveness, as the IFNg-R1 chain isusually in excess.

    The IFNg-R1 intracellular domain contains binding

    spots for the Jak 1, latent cytosolic factor, signaltransducer and activator of transcription (Stat1)

    IFNg only associates with IFNg-R2 when the IFNg-R1 chain is present.